Model
Edge
Vanda Pharmaceuticals
0001802653
Filing Type
4
Filing Date
8/10/2023
Updated
8/11/23, 10:36 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership